eFFECTOR Therapeutics Inc

NASDAQ:EFTR   3:59:56 PM EDT
0.44
-0.03 (-6.68%)
Earnings Announcements

eFFECTOR Therapeutics Inc Reports Q3 Diluted Loss Per Share Of $0.23

Published: 11/07/2022 21:59 GMT
eFFECTOR Therapeutics Inc (EFTR) - Effector Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Effector Therapeutics Inc - Qtrly Diluted Loss per Share $0.23.
Revenue is expected to be $1.11 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.